When the marketing summary and the approved terms disagree, the terms win
A closed private fund in Saudi Arabia was raising capital to buy minority stakes in two logistics companies. It came with two documents: a polished executive summary for investors, and the terms and conditions approved by the regulator. Most people read the first one. The second one is the one that binds you.
Reading them side by side, I logged twelve contradictions. The summary quoted a 1.75% management fee; the approved terms said 2%. The approved terms carried a 5% fee on M&A and exits, a 1% financing fee, a 1% unit-transfer fee and a 30% leverage cap, and none of them appeared in the summary. The hurdle rate was written in words as “ten percent” with “(13%)” in brackets beside it, an internal contradiction inside the regulator-approved document itself.
Then the structural one: the fund’s minimum initial closing was SAR 21M, while the minimum injection into its main target was SAR 50M. If the fund closed at its minimum, it could not fund the deal it was raised for.
None of this needs bad intent to happen. Marketing documents get written early and updated late; legal documents get negotiated and approved on their own track. But an investor signs the terms, not the brochure. My rule is simple: build the fee bridge from the approved terms, then reconcile the marketing numbers to it, never the other way round. On this case that bridge, together with a fair-value range of SAR 50–80M against a SAR 132M ask, turned an attractive pitch into a conditional hold.
